Audit confirms conclusions of UGDP study on oral diabetes drugs.
D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000150:complications / Q000401:mortality; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D010629:Phenformin / Q000009:adverse effects*; D014044:Tolbutamide / Q000009:adverse effects*
D014044:Tolbutamide; D010629:Phenformin